EC Paediatrics

Anxiety is a multifaceted emotional state associated with various neurophysiological alterations within the brain. Central to these changes are neurotransmitters, particularly serotonin and dopamine, which exert effects across numerous regions, orchestrating anxiety responses. The serotonergic system is widely implicated in the pathophysiology of anxiety disorders, alongside the dopaminergic system, which is recognized for its modulatory role in anxiety and related conditions like depression. Understanding the intricate balance between these systems can pave the way for novel therapeutic approaches for clinical anxiety.

 Keywords: Nerve Transmitters; Anxiety; Serotonergic System; Dopaminergic System

1. Lin J., et al. “Latest updates on the serotonergic system in depression and anxiety”. Frontiers in Synaptic Neuroscience 15 (2023): 1124112.
2. Hale MW., et al. “Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders”. Cellular and Molecular Neurobiology5 (2012): 695-708.
3. Lowry C., et al. “Modulation of anxiety circuits by serotonergic systems”. Stress4 (2005): 233-246.
4. Jain VK., et al. “Evaluation of anxiolytic activity of ondansetron in mice models - an animal experimental research”. Journal of Medical Sciences and Health 2 (2022): 106-112.
5. Grundmann O., et al. “Anti-anxiety effects of Apocynum venetum in the elevated plus maze test”. Journal of Ethnopharmacology 110.3 (2007): 406-411.
6. Fox JH and Lowry CA. “Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior”. Frontiers in Neuroscience 7 (2013): 169.
7. Donner NC., et al. “Crh receptor priming in the bed nucleus of the stria terminalis (bnst) induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety”. Progress in Neuro-Psychopharmacology and Biological Psychiatry 96 (2020): 109730.
8. Doruyter A., et al. “Nuclear neuroimaging in social anxiety disorder: a review”. Journal of Nuclear Medicine12 (2018): 1794-1800.
9. Gao L., et al. “Structural and functional alterations of substantia nigra and associations with anxiety and depressive symptoms following traumatic brain injury”. Frontiers in Neurology 13 (2022): 719778.
10. Mata-Bermúdez A., et al. “Dysregulation of the dopaminergic system secondary to traumatic brain injury: implications for mood and anxiety disorders”. Frontiers in Neuroscience 18 (2024): 1447688.
11. Donner N., et al. “Two models of inescapable stress increase tph2 mrna expression in the anxiety-related dorsomedial part of the dorsal raphe nucleus”. Neurobiology of Stress 8 (2018): 68-81.
12. Smagin DA., et al. “Chronic lithium treatment affects anxious behaviors and the expression of serotonergic genes in midbrain raphe nuclei of defeated male mice”. Biomedicines10 (2021): 1293.
13. Hale MW., et al. “Exposure to an open-field arena increases c-fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex”. Neuroscience4 (2008): 733-748.
14. Forster GL., et al. “Corticotropin‐releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity”. European Journal of Neuroscience2 (2008): 299-310.
15. Ratirat Sangpayap., et al. “Thunbergia laurifolia extract protects ethanol addiction and increases dopamine synthesis”. Tropical Journal of Natural Product Research 5.1 (2021): 53-61.
16. Theodoridi A., et al. “Acute exposure to fluoxetine alters aggressive behavior of zebrafish and expression of genes involved in serotonergic system regulation”. Frontiers in Neuroscience 11 (2017): 223.
17. Lowry C., et al. “Serotonergic systems, anxiety, and affective disorder”. Annals of the New York Academy of Sciences1 (2008): 86-94.